Summary

    Hubei Cancer Hospital (HBCH), also known as Hubei Cancer Institute, Hubei Cancer Hospital Affiliated to Tongji Medical College, Huazhong University of Science and Technology, was founded in 1973 and is a major Class A tertiary cancer hospital under the jurisdiction of the Health Commission of Hubei Province. HBCH is devoted to cancer prevention, treatment, rehabilitation, research and education. It has been awarded many prestigious titles over the years: the Sister Hospital of Buffett Cancer Center, Hubei Cancer Center, the Supporting Institute for Hubei Provincial Cancer Prevention Office, Designated Hospital for Medical Insurance in Hubei Province and Wuhan City, Designated Hospital for New Rural Cooperative Medical Care and Designated Hospital for Commercial Insurance. HBCH leads the work of Hubei Provincial Cancer Quality Control Center.

    Located at No.116 Zhuodaoquan South Road, Hongshan District, Wuhan, China, HBCH covers an area of 154,000 square meters, with a building area of 130,000 square meters and a green area of 90,000 square meters. It is the only provincial garden-style demonstration hospital in Wuhan, with the beautiful scenery on the north of South Lake.

    HBCH comprises 31 clinical departments and 11 medical technological departments with a total of 2,000 sickbeds, 10 laboratories combining basic and clinical research, national drug clinical trial base and postdoctoral workstation. In 2013, HBCH was awarded with the national key clinical specialty of oncology and the national project to improve the diagnosis and treatment abilities of difficult and complicated diseases.

    The departments of general surgery (gastrointestinal surgery, hepatobiliary and pancreatic, breast, head and neck), radiology, pathology and ultrasound are provincial key clinical specialties. Preponderant disciplines, such as radiotherapy, oncology, head and neck surgery, breast, thoracic surgery, gastrointestinal surgery, urology, hepatobiliary and pancreatic surgery, gynecologic oncology, and integrated Chinese and Western medicine, enjoy high reputation at home and abroad. The disciplines of oncology and tumor radiotherapy are rated as national key disciplines.

    HBCH is well-equipped with 6 electronic linear accelerators (including the first image guidance in Central and South China-rotary intensity-modulated radiotherapy system and EDGE), PET-CT, 3.0T magnetic resonance, high-end energy spectrum CT, large aperture simulation CT, ECT, large flat panel DSA, etc., to provide the patients with high-quality and efficient diagnosis and treatment services.

    HBCH has abundant talents and strong medical technology. Among its 1,419 staff members, 82 are with senior professional titles, 169 are with deputy senior professional titles and 255 are with intermediate professional titles; there are 1,217 health professionals, accounting for 85.8% of the total number of staff. There are 285 masters and doctors, among whom 82.8% are doctors.

    Since the reform and opening-up, HBCH focuses on the latest developments in domestic and international oncology, develops advanced medical techniques and treatment, adopts international advanced MDT treatment concept, adheres to the principle of systematic, standard, comprehensive treatment, combines multiple disciplines, such as traditional Chinese medicine and western medicine, and gradually forms the obvious advantage in all disciplines inside and outside the province. The comprehensive treatment levels of head and neck cancer, breast cancer, lung cancer, esophageal cancer, liver cancer, gastrointestinal cancer, gynecological cancer, urinary tract cancer and malignant lymphoma are at the forefront of China.

    HBCH is the standing committee unit of Chinese Medical Association Oncology Branch, the standing director unit of Chinese Anti-cancer Association, the chairman unit of Hubei Cancer Society, the chairman unit of Hubei Anti-cancer Association and the chairman unit of 14 professional committees under Hubei Anti-cancer Association. Some experts are elected as the committee members of the national and provincial professional societies. HBCH also has the Provincial Colorectal Cancer Medical Research Center, the Provincial Breast Disease Prevention and Treatment Research Center, the Provincial Stereotactic Radiotherapy Center, the Provincial Medical Equipment Maintenance Center and other institutions, to guide the provincial cancer medicine discipline construction and early diagnosis and treatment of cancer project. It establishes technical cooperation and counterpart support relationship with the First People's Hospital of Xianning and other hospitals, and undertakes the task of tumor professional teaching in medical colleges such as Tongji Medical College of Huazhong University of Science and Technology and the training of tumor professional technicians inside and outside Hubei province, to promote the continuous progress of tumor prevention and research in Hubei province

    HBCH has a long-term collaboration with MD Anderson Cancer Center, Medical College of Nebraska University, New Jersey Robert Wood John Medical College, Medical College of Nancy-Metz University, Australian Cancer Research Center and other cancer research institutions oversea. HBCH engaged Academician Daiming Fan, the vice president of Chinese Academy of Engineering，as the chief scientist. HBCH has also carried out scientific research cooperation with Huazhong University of Science and Technology, Huazhong Agricultural University, Wuhan University and other institutions of higher learning. In recent years, the hospital has undertaken more than 100 research projects, edited and published more than 50 monographs, and published more than 1,000 papers in international and domestic core journals.

    The journal of Cancer Research on Prevention and Treatment hosted by HBCH is the first independent national professional academic journal about cancer research. It is indexed by Scopus (Netherland), DOAJ (Sweden), EBSCO (the United States), ProQuest (the United States), CA (the United States), Ulrichweb (the United States), CABI (Britain), JSTChina (Japan),  IC (Poland), HINARI (Switzerland) and other major databases. 

    With the motto of "benefit the public with absolute sincerity, influence the ideology with lofty virtue", HBCH actively carries out lean management, discipline construction and the innovation of fine subspecialty subdivisions, multidisciplinary joint diagnosis and treatment, the standardized management of single diseases and chief expert system. The expert pattern of authoritative veteran doctors, middle-aged experts and young doctors has been improved day by day. The hospital deepens structural reform, strengthens discipline construction, adheres to the innovation of management, system, technology and service, and forms a sustained, stable, healthy and coordinated development situation, achieving favorable social benefits.